IL6 and neoplasm: Intriguingly, and in contrast to our observations, several recent studies have shown that combined blockade of IL-6 and PD-1/PD-L1 checkpoint molecules promotes tumor infiltration of IFN-γ-producing CD4+ T cells and exerts synergistic antitumor effects [42, 43].